Incannex Healthcare (IXHL) Net Income (2022 - 2026)
Incannex Healthcare (IXHL) posted Net Income of -$3.9 million for Q1 2026, up 40.45% sequentially from -$6.5 million in Q4 2025, and up 2.14% YoY from -$3.8 million in Q1 2025.
Incannex Healthcare (IXHL) Net Income (2022 - 2026) Analysis & Trends
Incannex Healthcare has reported Net Income for 5 years, with the latest figure at -$3.9 million in Q1 2026.
- Quarterly Net Income rose 2.14% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.4 million (down 122.97% YoY) and the FY2025 annual result came in at -$46.9 million, down 154.0% from the prior year.
- Net Income advanced to -$3.9 million in Q1 2026 per IXHL's latest filing, from -$6.5 million in the prior quarter.
- Over five years, Net Income peaked at -$726000.0 in Q3 2023 and troughed at -$31.6 million in Q2 2025.
- A 5-year average of -$6.6 million and a median of -$5.3 million in 2023 frame the typical range for Net Income.
- The sharpest annual moves came in 2024 and 2025: Net Income slumped 646.56% in 2024, then jumped 34.21% in 2025.
- Over 5 years, Net Income stood at -$2.9 million in 2022, then slumped by 79.61% to -$5.2 million in 2023, then decreased by 12.46% to -$5.9 million in 2024, then dropped by 10.64% to -$6.5 million in 2025, then surged by 40.45% to -$3.9 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered -$3.9 million, -$6.5 million, and -$6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -69.36 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Incannex Healthcare | 44.39 Mn | 44.39 Mn | - | -3.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.88 Mn |
| Dec 31, 2025 | -6.52 Mn |
| Sep 30, 2025 | -6.41 Mn |
| Jun 30, 2025 | -31.60 Mn |
| Mar 31, 2025 | -3.97 Mn |
| Dec 31, 2024 | -5.89 Mn |
| Sep 30, 2024 | -5.42 Mn |
| Jun 30, 2024 | -6.43 Mn |
| Mar 31, 2024 | -6.03 Mn |
| Dec 31, 2023 | -5.24 Mn |
| Sep 30, 2023 | -726,000.00 |
| Jun 30, 2023 | -4.17 Mn |
| Mar 31, 2023 | -3.57 Mn |
| Dec 31, 2022 | -2.92 Mn |